Repurposed antidepressant could be a new treatment for recurrent prostate cancer
A new interdisciplinary USC study shows that an antidepressant in use for decades, repurposed to fight prostate cancer, could help patients whose disease has returned following surgery or radiation.
The drug — an MAO inhibitor called phenelzine — represents a potential … Read More »